⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1997544 | 0.57 | — | — | |
| Potassium SCHEMBL30168527 | 0.56 | — | — | |
| SCHEMBL2638687 | 0.50 | — | — | |
| SCHEMBL28508440 | 0.48 | — | — | |
| Hydrochloric Acid SCHEMBL1026361 | 0.48 | — | — | |
| SCHEMBL5007434 | 0.47 | — | — | |
| SCHEMBL4584646 | 0.45 | — | — | |
| SCHEMBL13523738 | 0.44 | — | — | |
| SCHEMBL24459 | 0.44 | — | — | |
| Hydrochloric Acid SCHEMBL546609 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5843997-A | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1998-12-01 | — | — | US | claimed |
| WO-1997023471-A1 | 5-DIFLUOROMETHOXY-3-ARYL-1,2,4-THIADIAZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEMATICIDE AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-07-03 | — | — | WO | claimed |
| US-5576323-A | CENTRAL NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1996-11-19 | — | — | US | claimed |
| EP-0658539-A1 | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1995-06-21 | — | — | EP | claimed |
| EP-4168002-A1 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| US-20210284627-A1 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2021-09-16 | — | — | US | disclosed |
| EP-3766877-A1 | INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | Japan Tobacco Inc. (JP) | 2021-01-20 | — | — | EP | disclosed |
| US-20200255408-A1 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2020-08-13 | — | — | US | disclosed |
| US-20180362506-A1 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2018-12-20 | — | — | US | disclosed |
| US-20170267662-A1 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2017-09-21 | — | — | US | disclosed |
| EP-2759533-B1 | CONDENSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2017-08-02 | — | — | EP | disclosed |
| EP-2499691-B1 | METHOD FOR MECHANICALLY STABILIZING NITROGEN-CONTAINING POLYMERS | SAMSUNG ELECTRONICS CO LTD (KR) | 2017-07-12 | — | — | EP | disclosed |
| US-20050159438-A1 | Spirocyclic heterocyclic derivatives and methods of their use | ADOLOR CORPORATION | 2005-07-21 | — | — | US | disclosed |
| WO-2005033073-A2 | SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
| US-5843997-A | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1998-12-01 | — | — | US | disclosed |
| WO-1997023471-A1 | 5-DIFLUOROMETHOXY-3-ARYL-1,2,4-THIADIAZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEMATICIDE AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-07-03 | — | — | WO | disclosed |
| US-5576323-A | CENTRAL NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| EP-0658539-A1 | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1995-06-21 | — | — | EP | disclosed |
| US-5210204-A | Hypotensive agents and cardiovascular disorders | WARNER-LAMBERT COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-3943144-A | INSECTICIDE, MITICIDE | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |